BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 25823735)

  • 21. Bone marrow 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography cannot replace bone marrow biopsy in diffuse large B-cell lymphoma.
    Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM
    Am J Hematol; 2014 Jul; 89(7):726-31. PubMed ID: 24711255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative effectiveness and cost-effectiveness of computed tomography screening for coronary artery calcium in asymptomatic individuals.
    van Kempen BJ; Spronk S; Koller MT; Elias-Smale SE; Fleischmann KE; Ikram MA; Krestin GP; Hofman A; Witteman JC; Hunink MG
    J Am Coll Cardiol; 2011 Oct; 58(16):1690-701. PubMed ID: 21982314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness of para-aortic lymphadenectomy before chemoradiotherapy in locally advanced cervical cancer.
    Lee JY; Kim Y; Lee TJ; Jeon YW; Kim K; Chung HH; Kim HJ; Park SM; Kim JW
    J Gynecol Oncol; 2015 Jul; 26(3):171-8. PubMed ID: 25925292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Limited clinical benefit for surveillance PET-CT scanning in patients with histologically transformed lymphoma in complete metabolic remission following primary therapy.
    Cheah CY; Dickinson M; Hofman MS; George A; Ritchie DS; Prince HM; Westerman D; Harrison SJ; Burbury K; Wolf M; Januszewicz H; Herbert KE; Carney DA; Tam C; Seymour JF
    Ann Hematol; 2014 Jul; 93(7):1193-200. PubMed ID: 24595733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-Effectiveness of Reduced Waiting Time for Head and Neck Cancer Patients due to a Lean Process Redesign.
    Simons PA; Ramaekers B; Hoebers F; Kross KW; Marneffe W; Pijls-Johannesma M; Vandijck D
    Value Health; 2015 Jul; 18(5):587-96. PubMed ID: 26297086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Performing Gadoxetic Acid-Enhanced MRI After CT for Guiding Curative Treatment of Early-Stage Hepatocellular Carcinoma: A Cost-Effectiveness Analysis.
    Suh CH; Kim KW; Park SH; Kim SY; Woo DC; Shin S; Pyo J; Shinagare AB; Ramaiya NH; Lim YS
    AJR Am J Roentgenol; 2018 Feb; 210(2):W63-W69. PubMed ID: 29091004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Strikingly high false positivity of surveillance FDG-PET/CT scanning among patients with diffuse large cell lymphoma in the rituximab era.
    Avivi I; Zilberlicht A; Dann EJ; Leiba R; Faibish T; Rowe JM; Bar-Shalom R
    Am J Hematol; 2013 May; 88(5):400-5. PubMed ID: 23423884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In newly diagnosed diffuse large B-cell lymphoma, determination of bone marrow involvement with 18F-FDG PET/CT provides better diagnostic performance and prognostic stratification than does biopsy.
    Berthet L; Cochet A; Kanoun S; Berriolo-Riedinger A; Humbert O; Toubeau M; Dygai-Cochet I; Legouge C; Casasnovas O; Brunotte F
    J Nucl Med; 2013 Aug; 54(8):1244-50. PubMed ID: 23674577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metastatic colorectal carcinoma: cost-effectiveness of percutaneous radiofrequency ablation versus that of hepatic resection.
    Gazelle GS; McMahon PM; Beinfeld MT; Halpern EF; Weinstein MC
    Radiology; 2004 Dec; 233(3):729-39. PubMed ID: 15564408
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Value of surveillance studies for patients with stage I to II diffuse large B-cell lymphoma in the rituximab era.
    Hiniker SM; Pollom EL; Khodadoust MS; Kozak MM; Xu G; Quon A; Advani RH; Hoppe RT
    Int J Radiat Oncol Biol Phys; 2015 May; 92(1):99-106. PubMed ID: 25863757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fluorine-18-fluorodeoxyglucose Positron Emission Tomography in Diffuse Large B-cell Lymphoma.
    Mylam KJ; Nielsen AL; Pedersen LM; Hutchings M
    PET Clin; 2014 Oct; 9(4):443-55, vi. PubMed ID: 26050946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal artery stenosis: cost-effectiveness of diagnosis and treatment.
    van Helvoort-Postulart D; Dirksen CD; Nelemans PJ; Kroon AA; Kessels AG; de Leeuw PW; Vasbinder GB; van Engelshoven JM; Hunink MG
    Radiology; 2007 Aug; 244(2):505-13. PubMed ID: 17581886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is FDG PET/CT cost-effective for pre-operation staging of potentially operative non-small cell lung cancer? - From Chinese healthcare system perspective.
    Wang YT; Huang G
    Eur J Radiol; 2012 Aug; 81(8):e903-9. PubMed ID: 22698711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The cost-utility analysis of 18-fluoro-2-deoxyglucose positron emission tomography in the diagnosis of recurrent nasopharyngeal carcinoma.
    Yen RF; Yen MF; Hong RL; Tzen KY; Chien CR; Chen TH
    Acad Radiol; 2009 Jan; 16(1):54-60. PubMed ID: 19064212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-effectiveness of routine (18)F-FDG PET/CT in high-risk patients with gram-positive bacteremia.
    Vos FJ; Bleeker-Rovers CP; Kullberg BJ; Adang EM; Oyen WJ
    J Nucl Med; 2011 Nov; 52(11):1673-8. PubMed ID: 21984799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The value of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for staging of primary extranodal head and neck lymphomas.
    Schrepfer T; Haerle SK; Strobel K; Schaefer N; Hälg RA; Huber GF
    Laryngoscope; 2010 May; 120(5):937-44. PubMed ID: 20422687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Children with suspected craniosynostosis: a cost-effectiveness analysis of diagnostic strategies.
    Medina LS; Richardson RR; Crone K
    AJR Am J Roentgenol; 2002 Jul; 179(1):215-21. PubMed ID: 12076939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Consistency of FDG-PET accuracy and cost-effectiveness in initial staging of patients with Hodgkin lymphoma across jurisdictions.
    Cerci JJ; Trindade E; Buccheri V; Fanti S; Coutinho AM; Zanoni L; Linardi CC; Celli M; Delbeke D; Pracchia LF; Pitela FA; Soares J; Zinzani PL; Meneghetti JC
    Clin Lymphoma Myeloma Leuk; 2011 Aug; 11(4):314-20. PubMed ID: 21816369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-effectiveness analysis of PET-CT-guided management for locally advanced head and neck cancer.
    Smith AF; Hall PS; Hulme CT; Dunn JA; McConkey CC; Rahman JK; McCabe C; Mehanna H
    Eur J Cancer; 2017 Nov; 85():6-14. PubMed ID: 28881249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suspected carotid artery stenosis: cost-effectiveness of CT angiography in work-up of patients with recent TIA or minor ischemic stroke.
    Tholen AT; de Monyé C; Genders TS; Buskens E; Dippel DW; van der Lugt A; Hunink MG
    Radiology; 2010 Aug; 256(2):585-97. PubMed ID: 20656842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.